Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck × Olanzapine × 90 days × Clear all

NCT06995508 2026-02-17

Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck